[FG] Leuppi-Taegtmeyer Anne

Boesing, Maria et al. (2024) ‘Effects of serial NT-proBNP measurements in patients with acute decompensated heart failure: Results of the POC-HF pilot trial’, Global Cardiology Science and Practice, 2024(4). Available at: https://doi.org/10.21542/gcsp.2024.31.

Brüne, Birgit et al. (2024) ‘Assessing potential risk factors for metamizole-induced leukopenia’, Therapeutic Advances in Drug Safety, 15. Available at: https://doi.org/10.1177/20420986241275255.

Lüthi-Corridori, Giorgia et al. (2024) ‘Diagnosis and Therapy of Community-Acquired Pneumonia in the Emergency Department: A Retrospective Observational Study and Medical Audit’, Journal of Clinical Medicine, 13. Available at: https://doi.org/10.3390/jcm13020574.

Isaak J et al. (2023) ‘Diagnostic Workup and Outcome in Patients with Profound Hyponatremia.’, Journal of clinical medicine, 12(10). Available at: https://doi.org/10.3390/jcm12103567.

Jaun F et al. (2023) ‘Effect of Single High Dose Vitamin D Substitution in Hospitalized COVID-19 Patients with Vitamin D Deficiency on Length of Hospital Stay.’, Biomedicines, 11(5). Available at: https://doi.org/10.3390/biomedicines11051277.

Boesing M et al. (2023) ‘Predictors for Unplanned Readmissions within 18 Days after Hospital Discharge: a Retrospective Cohort Study.’, Praxis, 112(2), pp. 57–63. Available at: https://doi.org/10.1024/1661-8157/a003985.

Lüthi-Corridori G et al. (2023) ‘Risk factors for hospital outcomes in pulmonary embolism: A retrospective cohort study.’, Frontiers in medicine, 10, p. 1120977. Available at: https://doi.org/10.3389/fmed.2023.1120977.

Lüthi-Corridori, Giorgia et al. (2023) ‘Predictors of Length of Stay, Mortality and Rehospitalization in COPD Patients: A Retrospective Cohort Study’, Journal of Clinical Medicine, 12. Available at: https://doi.org/10.3390/jcm12165322.

Lüthi-Corridori, Giorgia et al. (2023) ‘Predictors of Length of Stay, Rehospitalization and Mortality in Community-Acquired Pneumonia Patients: A Retrospective Cohort Study’, Journal of Clinical Medicine, 12. Available at: https://doi.org/10.3390/jcm12175601.

Mandovra, N.P. et al. (2023) ‘Factors Affecting Best-Tolerated Dose of Pirfenidone in Patients with Fibrosing Interstitial Lung Disease’, Journal of Clinical Medicine, 12(20), p. 6513. Available at: https://doi.org/10.3390/jcm12206513.

Mbata, Munachimso Kizito et al. (2023) ‘The Correct Indication to Induce Labour in a Swiss Cantonal Hospital’, Journal of Clinical Medicine, 12. Available at: https://doi.org/10.3390/jcm12206515.

Mbata, Munachimso Kizito et al. (2023) ‘Is Serum 25-Hydroxyvitamin D Level Associated with Severity of COVID-19? A Retrospective Study’, Journal of Clinical Medicine, 12. Available at: https://doi.org/10.3390/jcm12175520.

Mehra, Tarun et al. (2023) ‘Pre-treatment comorbidities, C-reactive protein and eosinophil count, and immune-related adverse events as predictors of survival with checkpoint inhibition for multiple tumour entities’, Cancer Medicine, 12, pp. 12253–12262. Available at: https://doi.org/10.1002/cam4.5919.

Schnyder D et al. (2023) ‘Audit of Asthma Exacerbation Management in a Swiss General Hospital.’, Respiration; international review of thoracic diseases, 102(1), pp. 12–24. Available at: https://doi.org/10.1159/000527268.

Späni, Selina N. et al. (2023) ‘Polymedication and oral antitumour therapies - which drug interactions should be considered?’, Therapeutische Umschau. Revue therapeutique, 80, pp. 373–376.

Taegtmeyer H, Ganim J and Leuppi-Taegtmeyer AB (2023) ‘Hermann (‘Hugh’) Blaschko (1900-1993): Father of Catecholamine Metabolism.’, 148(2). Available at: https://doi.org/10.1159/000528895.

Vetter, Marcus et al. (2023) ‘Integrating Geriatric Care in Clinical Oncology Practice: Recommendations from an Interdisciplinary Professional Survey Study in a Single-Cancer Center in Switzerland’, Healthbook TIMES Oncology Hematology, 16, pp. 14–19. Available at: https://doi.org/10.36000/hbt.oh.2023.16.106.

Dongre K et al. (2022) ‘Disease-Drug Interactions Requiring Special Attention.’, Praxis, 111(12), pp. 700–705. Available at: https://doi.org/10.1024/1661-8157/a003923.

Jaun F et al. (2022) ‘High-dose vitamin D substitution in patients with COVID-19: study protocol for a randomized, double-blind, placebo-controlled, multi-center study-VitCov Trial.’, Trials, 23(1), p. 114. Available at: https://doi.org/10.1186/s13063-022-06016-2.

Battegay R et al. (2021) ‘Immune thrombocytopenia associated with COVID-19 mRNA vaccine tozinameran - a clinical case and global pharmacovigilance data.’, Swiss medical weekly, 151, p. w30084. Available at: https://doi.org/10.4414/smw.2021.w30084.

Tschacher A et al. (2021) ‘Switching COPD patients from the disposable to the new reusable Respimat soft mist inhaler: a real-world study from Switzerland.’, Current medical research and opinion, 37(11), pp. 2019–2033. Available at: https://doi.org/10.1080/03007995.2021.1969354.

Istampoulouoglou I et al. (2021) ‘Myocarditis and pericarditis in association with COVID-19 mRNA-vaccination: cases from a regional pharmacovigilance centre.’, Global cardiology science & practice, 2021(3), p. e202118. Available at: https://doi.org/10.21542/gcsp.2021.18.

Hollinger A et al. (2021) ‘Lactic acidosis and hyperlactatemia associated with lamivudine accumulation and sepsis in a kidney transplant recipient-a case report and review of the literature.’, AIDS research and therapy, 18(1), p. 56. Available at: https://doi.org/10.1186/s12981-021-00382-8.

Cittone MG et al. (2021) ‘The statistical risk of diagnosing coincidental acquired hemophilia A following anti-SARS-CoV-2 vaccination.’, 19(9). Available at: https://doi.org/10.1111/jth.15421.

Istampoulouoglou I et al. (2021) ‘Cardiovascular adverse effects of lopinavir/ritonavir and hydroxychloroquine in COVID-19 patients: Cases from a single pharmacovigilance centre.’, Global cardiology science & practice, 2021(2), p. e202111. Available at: https://doi.org/10.21542/gcsp.2021.11.

Lehmann A et al. (2021) ‘A case of intoxication with tea made from Digitalis purpurea.’, Global cardiology science & practice, 2021(1), p. e202102. Available at: https://doi.org/10.21542/gcsp.2021.2.

Marzolini C et al. (2021) ‘Sex Differences in Lopinavir Concentrations and Occurrence of Marked QTc Prolongation Episodes in Patients with COVID-19.’, 44(2). Available at: https://doi.org/10.1007/s40264-020-01025-z.

Arranto CA et al. (2021) ‘Prevalence of untreated and uncontrolled cardiovascular risk factors in survivors of allogeneic cell transplantation.’, Bone marrow transplantation, 56(1), pp. 167–174. Available at: https://doi.org/10.1038/s41409-020-00997-x.

Blaser, Lea S. et al. (2021) ‘Comparative Effects of Metamizole (Dipyrone) and Naproxen on Renal Function and Prostacyclin Synthesis in Salt-Depleted Healthy Subjects - A Randomized Controlled Parallel Group Study’, Frontiers in Pharmacology, 12, p. 620635. Available at: https://doi.org/10.3389/fphar.2021.620635.

El Saghir A et al. (2021) ‘Development and Implementation of an e-Trigger Tool for Adverse Drug Events in a Swiss University Hospital.’, Drug, healthcare and patient safety, 13, pp. 251–263. Available at: https://doi.org/10.2147/dhps.s334987.

Leuppi-Taegtmeyer, Anne B. et al. (2021) ‘Antiseizure drugs and risk of developing smoking-related chronic obstructive pulmonary disease or lung cancer: A population-based case-control study’, British Journal of Clinical Pharmacology, 87(3), pp. 1253–1263. Available at: https://doi.org/10.1111/bcp.14501.

Späni S, Hübner ST and Leuppi-Taegtmeyer A (2021) ‘[Cough from a pharmacological point of view].’, Therapeutische Umschau. Revue therapeutique, 78(4), pp. 195–198. Available at: https://doi.org/10.1024/0040-5930/a001259.

Gotta V et al. (2020) ‘Intensive Hemodiafiltration Successfully Removes Ganciclovir Overdose and Largely Exceeds Reported Elimination During Hemodialysis-A Case Report and Review of the Literature.’, 11. Available at: https://doi.org/10.3389/fphar.2020.00882.

Leuppi-Taegtmeyer A. and Strasser J (2020) ‘[Opioid Agonist Therapy (OAT) for opioid dependency].’, Therapeutische Umschau. Revue therapeutique, 77(1), pp. 29–36. Available at: https://doi.org/10.1024/0040-5930/a001148.

Mandovra NP et al. (2020) ‘High Incidence of New-Onset Joint Pain in Patients on Fluoroquinolones as Antituberculous Treatment.’, Respiration; international review of thoracic diseases, 99(2), pp. 125–131. Available at: https://doi.org/10.1159/000505102.

Manjaly Thomas, Zita-Rose et al. (2020) ‘Emerging treatments in COVID-19: Adverse drug reactions including drug hypersensitivities’, Journal Of Allergy And Clinical Immunology, 146(4), pp. 786–789. Available at: https://doi.org/10.1016/j.jaci.2020.07.008.

Pfefferkorn F et al. (2020) ‘[Opioids in patients with renal impairment].’, Therapeutische Umschau. Revue therapeutique, 77(1), pp. 10–13. Available at: https://doi.org/10.1024/0040-5930/a001144.

Weisshaar, Kimmo et al. (2020) ‘Development of a patient-reported outcome questionnaire for aplastic anemia and paroxysmal nocturnal hemoglobinuria (PRO-AA/PNH)’, Orphanet journal of rare diseases : OJRD, 15(1), p. 249. Available at: https://doi.org/10.1186/s13023-020-01532-3.

Dieu LW et al. (2019) ‘Prevalence of high-risk drug-drug interactions in paediatric inpatients: a retrospective, single-centre cohort analysis.’, Swiss medical weekly, 149, p. w20103. Available at: https://doi.org/10.4414/smw.2019.20103.

Skaistys A et al. (2019) ‘[Fatal Outcome of Agranulocytosis after Re-Exposure to Metamizole and Cefepime-Induced Encephalopathy].’, Praxis, 108(10), pp. 693–697. Available at: https://doi.org/10.1024/1661-8157/a003275.

Brockhaus L et al. (2019) ‘Hypersensitivity reaction with multi-organ failure following re-exposure to rifampicin: case report and review of the literature including WHO spontaneous safety reports.’, BMC pharmacology & toxicology, 20(1), p. 9. Available at: https://doi.org/10.1186/s40360-019-0289-7.

Leuppi-Taegtmeyer AB et al. (2019) ‘Multicenter population pharmacokinetic study of colistimethate sodium and colistin dosed as in normal renal function in patients on continuous renal replacement therapy’, Antimicrobial Agents and Chemotherapy. 29.01.2019, 63(2). Available at: https://doi.org/10.1128/aac.01957-18.

Bühler T et al. (2019) ‘Febrile illness and bicytopenia within hours after tick-borne encephalitis booster vaccination.’, 4. Available at: https://doi.org/10.1038/s41541-019-0152-2.

Bühler, Tim et al. (2019) ‘Hepatotoxicity Due to Azole Antimycotic Agents in a HLA B*35:02-Positive Patient’, Frontiers in pharmacology, 10, p. 645. Available at: https://doi.org/10.3389/fphar.2019.00645.

Gregoriano, Claudia et al. (2019) ‘Does a tailored intervention to promote adherence in patients with chronic lung disease affect exacerbations? A randomized controlled trial’, Respiratory research, 20(1), p. 273. Available at: https://doi.org/10.1186/s12931-019-1219-3.

Leuppi-Taegtmeyer, Anne et al. (2019) ‘Pharmacokinetics of oxycodone/naloxone and its metabolites in patients with end-stage renal disease during and between haemodialysis sessions’, Nephrology, Dialysis, Transplantation, 34(4), pp. 692–702. Available at: https://doi.org/10.1093/ndt/gfy285.

Ruperti-Repilado, Francisco Javier et al. (2019) ‘Danger of Herbal Tea: A Case of Acute Cholestatic Hepatitis Due to; Artemisia annua; Tea’, Frontiers in medicine, 6, p. 221. Available at: https://doi.org/10.3389/fmed.2019.00221.

Premstaller M et al. (2018) ‘Dyslipidemia and lipid-lowering treatment in a hematopoietic stem cell transplant cohort: 25 years of follow-up data.’, Journal of clinical lipidology. 06.12.2017, 12(2), pp. 464–480.e3. Available at: https://doi.org/10.1016/j.jacl.2017.11.008.

Hübner, Simona T et al. (2018) ‘C-Reactive Protein and Procalcitonin in Case Reports of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome.’, International archives of allergy and immunology, 176(1), pp. 44–54. Available at: https://doi.org/10.1159/000487670.

Salem M et al. (2017) ‘Torsade de pointes and systemic azole antifungal agents: Analysis of global spontaneous safety reports.’, Global cardiology science & practice, 2017(2), p. 11. Available at: https://doi.org/10.21542/gcsp.2017.11.

Blaser, Lea et al. (2017) ‘Leucopenia associated with metamizole: a case-control study’, Swiss medical weekly, 147, p. w14438. Available at: https://doi.org/10.4414/smw.2017.14438.

Hammann, Felix et al. (2017) ‘Pharmacokinetic interaction between taxanes and amiodarone leading to severe toxicity’, British Journal of Clinical Pharmacology, 83(4), pp. 927–930. Available at: https://doi.org/10.1111/bcp.13155.

Salili, Ali Reza et al. (2016) ‘Response to Letter From Ruan and Bumgarner: Breakthrough Pain Associated With a Reduction in Serum Buprenorphine Concentration During Dialysis.’, 38(3). Available at: https://doi.org/10.1016/j.clinthera.2015.12.013.

Hammann, Felix et al. (2016) ‘Severe taxane skin reaction due to a drug interaction with amiodarone: a case report’. TAYLOR & FRANCIS LTD, 54.

Salili AR et al. (2016) ‘Breakthrough Pain Associated with a Reduction in Serum Buprenorphine Concentration during Dialysis.’, Clinical therapeutics, 38(1), pp. 212–5. Available at: https://doi.org/10.1016/j.clinthera.2015.10.009.

Zeiner E et al. (2015) ‘[Fatal agranulocytosis after metamizole reexposure].’, Praxis, 104(3), pp. 151–4. Available at: https://doi.org/10.1024/1661-8157/a001916.

Schafroth Török,Salome et al. (2014) ‘An open-label study examining the effect of pharmacological treatment on mannitol- and exercise-induced airway hyperresponsiveness in asthmatic children and adolescents with exercise-induced bronchoconstriction.’, BMC pediatrics. 02.08.2014, 14, p. 196. Available at: https://doi.org/10.1186/1471-2431-14-196.

Smolenski,Ryszard T et al. (2014) ‘AMP deaminase 1 gene polymorphism and heart disease-a genetic association that highlights new treatment.’, Cardiovascular drugs and therapy, 28(2), pp. 183–9. Available at: https://doi.org/10.1007/s10557-013-6506-5.

Ceschi, Alessandro et al. (2014) ‘Acute mycophenolate overdose : case series and systematic literature analysis’, Expert opinion on drug safety, 13(5), pp. 525–34. Available at: https://doi.org/10.1517/14740338.2014.903032.

Gregoriano, Claudia et al. (2014) ‘Acute thiopurine overdose : analysis of reports to a National Poison Centre 1995-2013’, PLoS ONE, 9(1), p. e86390. Available at: https://doi.org/10.1371/journal.pone.0086390.

Taegtmeyer, Anne B. et al. (2014) ‘A study of the relationship between serum bile acids and propranolol pharmacokinetics and pharmacodynamics in patients with liver cirrhosis and in healthy controls’, PLoS ONE, 9(6). Available at: https://doi.org/10.1371/journal.pone.0097885.

Schreglmann, S R et al. (2013) ‘Multifocal CNS demyelination after octreotide treatment for metastatic meningioma.’, Clinical neurology and neurosurgery. 05.08.2012, 115(6), pp. 817–9. Available at: https://doi.org/10.1016/j.clineuro.2012.07.021.

Osthoff,Mirjam et al. (2013) ‘Bronchial hyperresponsiveness testing in athletes of the Swiss Paralympic team.’, BMC sports science, medicine & rehabilitation. 15.04.2013, 5(1), p. 7. Available at: https://doi.org/10.1186/2052-1847-5-7.

Scherr,Andreas et al. (2012) ‘Response to add-on inhaled corticosteroids in COPD based on airway hyperresponsiveness to mannitol.’, Chest, 142(4), pp. 919–926. Available at: https://doi.org/10.1378/chest.11-2535.

Taegtmeyer, Anne B. et al. (2012) ‘Drug-related problems and factors influencing acceptance of clinical pharmacologists” alerts in a large cohort of neurology inpatients’, SWISS MEDICAL WEEKLY. WOS.SCI, 142. Available at: https://doi.org/10.4414/smw.2012.13615.

Corti, N and Taegtmeyer, A B (2012) ‘[Clinically important food-drug interactions: what the practitioner needs to know].’, Praxis, 101(13), pp. 849–55. Available at: https://doi.org/10.1024/1661-8157/a000978.

Taegtmeyer, Anne, Curkovic, Ivanka and Corti, Natascia (2012) ‘[Interaction of drugs with the primary disease - when medicines exacerbate illnesses].’, Praxis, 101(6), pp. 363–70. Available at: https://doi.org/10.1024/1661-8157/a000877.

Taegtmeyer,A B et al. (2012) ‘Clinical usefulness of electronic drug-drug interaction checking in the care of cardiovascular surgery inpatients.’, Cardiology. 27.11.2012, 123(4), pp. 219–22. Available at: https://doi.org/10.1159/000343272.

Taegtmeyer,Anne B, Leuppi,Jörg D and Kullak-Ublick,Gerd A (2012) ‘Roflumilast--a phosphodiesterase-4 inhibitor licensed for add-on therapy in severe COPD.’, Swiss medical weekly, 142, p. w13628. Available at: https://doi.org/10.4414/smw.2012.13628.

Taegtmeyer, Anne B. et al. (2011) ‘Electronic prescribing increases uptake of clinical pharmacologists” recommendations in the hospital setting’, British Journal of Clinical Pharmacology, 72(6), pp. 958–964. Available at: https://doi.org/10.1111/j.1365-2125.2011.04032.x.

Taegtmeyer, Anne B et al. (2011) ‘Effect of continuous venovenous hemodiafiltration on darunavir and raltegravir exposure after administration via a gastroduodenal tube’, AIDS, 25(10), pp. 1339–1341. Available at: https://doi.org/10.1097/qad.0b013e328347f40d.

Gonzenbach, Roman R et al. (2011) ‘Fluoxetine and motor recovery after ischaemic stroke’, The Lancet Neurology, 10(6), pp. 499–500. Available at: https://doi.org/10.1016/s1474-4422(11)70112-0.

Taegtmeyer, Anne B. et al. (2011) ‘Effect of ABCB1 Genotype on Pre- and Post-Cardiac Transplantation Plasma Lipid Concentrations’, Journal of Cardiovascular Translational Research, 4(3), pp. 304–312. Available at: https://doi.org/10.1007/s12265-011-9269-z.

Olmos, David et al. (2011) ‘Phase I Study of GSK461364, a Specific and Competitive Polo-like Kinase 1 Inhibitor, in Patients with Advanced Solid Malignancies’, Clinical Cancer Research, 17(10), pp. 3420–3430. Available at: https://doi.org/10.1158/1078-0432.ccr-10-2946.